Batavia Biosciences Expands Its Viral Vector And GMP Facilities To...

Today, Batavia Biosciences announces the expansion of its viral vector process development facilities in...(PRWeb October 16, 2017)Read the full story at http://www.prweb.com/releases/2017/10/prweb14802217.htm

Source: PRWeb: Medical Pharmaceuticals - October 16, 2017 Category: Pharmaceuticals Source Type: news